Trial intelligence / Profile preview

Anti-inflammatory effects of topical erythromycin and clindamycin in inflammatory facial acne

2017-003105-18Phase 4Completed

Sponsor
Centre for Human Drug Research
Start
Dec 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, single-blind trial in acne vulgaris comparing Topical erythromycin 4% gel, Topical clindamycin 1% lotion and Topical placebo (3 arms). Started Dec 2017; status: completed.

02

Drugs

erythromycinclindamycin
03

Conditions

acne vulgaris

Beyond the preview

Go deeper on 2017-003105-18.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2017-003105-18.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call